IFIH1 and interstitial lung disease: Life expectancy can vary widely, e.g. from 8 years post-diagnosis in RA-ILD [17] to 6-month survival rates of 33–66% in those with rapidly progressive melanoma differentiation-associated protein 5–positive IIM-ILD [18].